125 related articles for article (PubMed ID: 38172007)
1. Primary care diabetes assessment when HbA1c and other measures of glycemia disagree.
Friedman JG; Smith EP; Awasty SS; Behan M; Genco MT; Hempel H; Jafri S; Jandarov R; Nagaraj T; Franco RS; Cohen RM
Prim Care Diabetes; 2024 Apr; 18(2):151-156. PubMed ID: 38172007
[TBL] [Abstract][Full Text] [Related]
2. Continuous Glucose Monitoring and Use of Alternative Markers To Assess Glycemia in Chronic Kidney Disease.
Zelnick LR; Batacchi ZO; Ahmad I; Dighe A; Little RR; Trence DL; Hirsch IB; de Boer IH
Diabetes Care; 2020 Oct; 43(10):2379-2387. PubMed ID: 32788282
[TBL] [Abstract][Full Text] [Related]
3. The interrelationships of glycemic control measures: HbA1c, glycated albumin, fructosamine, 1,5-anhydroglucitrol, and continuous glucose monitoring.
Beck R; Steffes M; Xing D; Ruedy K; Mauras N; Wilson DM; Kollman C;
Pediatr Diabetes; 2011 Dec; 12(8):690-5. PubMed ID: 21496193
[TBL] [Abstract][Full Text] [Related]
4. Hemoglobin A
Chan CL; Hope E; Thurston J; Vigers T; Pyle L; Zeitler PS; Nadeau KJ
Diabetes Care; 2018 Jul; 41(7):1406-1413. PubMed ID: 29674323
[TBL] [Abstract][Full Text] [Related]
5. The Accuracy of Hemoglobin A1c and Fructosamine Evaluated by Long-Term Continuous Glucose Monitoring in Patients with Type 2 Diabetes Undergoing Hemodialysis.
Bomholt T; Rix M; Almdal T; Knop FK; Rosthøj S; Heinrich NS; Jørgensen MB; Larsson A; Hilsted L; Feldt-Rasmussen B; Hornum M
Blood Purif; 2022; 51(7):608-616. PubMed ID: 34583354
[TBL] [Abstract][Full Text] [Related]
6. Glycated Albumin Correlates With Time-in-Range Better Than HbA1c or Fructosamine.
Desouza CV; Rosenstock J; Kohzuma T; Fonseca VA
J Clin Endocrinol Metab; 2023 Oct; 108(11):e1193-e1198. PubMed ID: 37259605
[TBL] [Abstract][Full Text] [Related]
7. Hemoglobin A1c and Fructosamine Evaluated in Patients with Type 2 Diabetes Receiving Peritoneal Dialysis Using Long-Term Continuous Glucose Monitoring.
Bomholt T; Feldt-Rasmussen B; Butt R; Borg R; Sarwary MH; Elung-Jensen T; Almdal T; Knop FK; Nørgaard K; Ranjan AG; Larsson A; Rix M; Hornum M
Nephron; 2022; 146(2):146-152. PubMed ID: 34731864
[TBL] [Abstract][Full Text] [Related]
8. Alternate glycemic markers reflect glycemic variability in continuous glucose monitoring in youth with prediabetes and type 2 diabetes.
Chan CL; Pyle L; Kelsey MM; Newnes L; Baumgartner A; Zeitler PS; Nadeau KJ
Pediatr Diabetes; 2017 Nov; 18(7):629-636. PubMed ID: 27873436
[TBL] [Abstract][Full Text] [Related]
9. Salivary protein glycosylation as a noninvasive biomarker for assessment of glycemia.
Rao PV; Laurie A; Bean ES; Roberts CT; Nagalla SR
J Diabetes Sci Technol; 2015 Jan; 9(1):97-104. PubMed ID: 25305283
[TBL] [Abstract][Full Text] [Related]
10. Screening for type 2 diabetes and prediabetes in obese youth: evaluating alternate markers of glycemia - 1,5-anhydroglucitol, fructosamine, and glycated albumin.
Chan CL; Pyle L; Kelsey M; Newnes L; Zeitler PS; Nadeau KJ
Pediatr Diabetes; 2016 May; 17(3):206-11. PubMed ID: 25652226
[TBL] [Abstract][Full Text] [Related]
11. Novel Biochemical Markers of Glycemia to Predict Pregnancy Outcomes in Women With Type 1 Diabetes.
Meek CL; Tundidor D; Feig DS; Yamamoto JM; Scott EM; Ma DD; Halperin JA; Murphy HR; Corcoy R;
Diabetes Care; 2021 Mar; 44(3):681-689. PubMed ID: 33495292
[TBL] [Abstract][Full Text] [Related]
12. Association of fructosamine to indices of dyslipidemia in older adults with type 2 diabetes.
Innes KE; Selfe TK; Vishnu A
Diabetes Metab Syndr; 2011; 5(4):179-82. PubMed ID: 25572758
[TBL] [Abstract][Full Text] [Related]
13. Continuous glucose monitoring and advanced glycation endproducts for prediction of clinical outcomes and development of cystic fibrosis-related diabetes in adults with CF.
Scully KJ; Brenner L; Martin K; Ruazol M; Sawicki GS; Uluer A; Neuringer I; Yonker LM; Sicilian L; Putman MS
Front Endocrinol (Lausanne); 2024; 15():1293709. PubMed ID: 38379863
[TBL] [Abstract][Full Text] [Related]
14. A comparison of fructosamine and HbA1c for home self-monitoring blood glucose levels in type 2 diabetes.
Chen HS; Chen RL; Chang ZY; Li HD
Zhonghua Yi Xue Za Zhi (Taipei); 2002 Apr; 65(4):151-5. PubMed ID: 12135193
[TBL] [Abstract][Full Text] [Related]
15. How does CKD affect HbA1c?
Bloomgarden Z; Handelsman Y
J Diabetes; 2018 Apr; 10(4):270. PubMed ID: 29124865
[TBL] [Abstract][Full Text] [Related]
16. [Diagnosis of the diabetic metabolic status using fructosamine (and HbA1c) determination. The glycation quotient Glyc-Q, the glycation nomogram].
Henrichs HR
Wien Klin Wochenschr Suppl; 1990; 180():64-9; discussion 78-81. PubMed ID: 2321396
[TBL] [Abstract][Full Text] [Related]
17. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.
Vos FE; Schollum JB; Coulter CV; Manning PJ; Duffull SB; Walker RJ
Nephrology (Carlton); 2012 Feb; 17(2):182-8. PubMed ID: 21883672
[TBL] [Abstract][Full Text] [Related]
18. Frequency of HbA1c discordance in estimating blood glucose control.
Cohen RM; Smith EP
Curr Opin Clin Nutr Metab Care; 2008 Jul; 11(4):512-7. PubMed ID: 18542015
[TBL] [Abstract][Full Text] [Related]
19. Continuous glucose monitoring and its relationship to hemoglobin A1c and oral glucose tolerance testing in obese and prediabetic youth.
Chan CL; Pyle L; Newnes L; Nadeau KJ; Zeitler PS; Kelsey MM
J Clin Endocrinol Metab; 2015 Mar; 100(3):902-10. PubMed ID: 25532041
[TBL] [Abstract][Full Text] [Related]
20. Beyond HbA1c.
Bloomgarden Z
J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
